113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

12 trials found

diseases per page:

Showing 1 to 10 of 12 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02836418 (ClinicalTrials.gov)	July 12, 2016	30/6/2016	Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940in Patients ...	An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activit ...	Facioscapulohumeral Muscular Dystrophy;Limb Girdle Muscular Dystrophy	Drug: ATYR1940	aTyr Pharma, Inc.	NULL	Completed	16 Years	25 Years	All	8	Phase 1/Phase 2	United States;Denmark;Italy
2	EUCTR2016-000624-25-DK (EUCTR)	22/06/2016	19/04/2016	An Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940in Patie ...	An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activit ...	Limb Girdle Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy MedDRA version: 19.0;Level ...	Product Name: ATYR1940 Product Code: ATYR1940 INN or Proposed INN: Not available yet Other descriptive ...	aTyr Pharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	22	Phase 1;Phase 2	United States;Denmark;Italy
3	NCT02603562 (ClinicalTrials.gov)	March 30, 2016	5/11/2015	Evaluate Safety and Biological Activity of ATYR1940in Patients With Early Onset Facioscapulohumeral ...	An Open-Label, Intrapatient Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenici ...	Facioscapulohumeral Muscular Dystrophy (FSHD)	Biological: ATYR1940;Biological: Placebo	aTyr Pharma, Inc.	NULL	Completed	12 Years	25 Years	All	8	Phase 1/Phase 2	United States;France;Italy
4	EUCTR2015-001910-88-DK (EUCTR)	17/12/2015	30/06/2015	A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940in ...	An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenici ...	Limb Girdle Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy MedDRA version: 19.0;Level ...	Product Name: ATYR1940 Product Code: ATYR1940 INN or Proposed INN: Not available yet	aTyr Pharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	16	Phase 1;Phase 2	France;United States;Denmark;Italy
5	NCT02579239 (ClinicalTrials.gov)	November 5, 2015	28/9/2015	The Safety and Biological Activity of ATYR1940in Patients With Limb Girdle or Facioscapulohumeral Mu ...	An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenici ...	Limb-Girdle Muscular Dystrophies;Facioscapulohumeral Muscular Dystrophy	Biological: ATYR1940;Biological: Placebo	aTyr Pharma, Inc.	NULL	Completed	18 Years	75 Years	All	18	Phase 1/Phase 2	United States;Denmark;France;Italy
6	NCT02531217 (ClinicalTrials.gov)	September 2015	25/6/2015	Safety, Tolerability, PK, and Activity of ATYR1940in Patients With Muscular Dystrophy - Study Extens ...	An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, Biological Activity, a ...	Facioscapulohumeral Muscular Dystrophy	Biological: ATYR1940	aTyr Pharma, Inc.	NULL	Completed	18 Years	65 Years	All	9	Phase 1/Phase 2	United States;Italy;Netherlands
7	EUCTR2015-001912-36-NL (EUCTR)	04/08/2015	22/06/2015	A Study to Evaluate the Long-Term Safety, Tolerability, Biological Activity, and Exposure of ATYR194 ...	An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, Biological Activity, a ...	Facioscapulohumeral muscular dystrophy MedDRA version: 19.0;Level: PT;Classification code 10064087;T ...	Product Name: ATYR1940 Product Code: ATYR1940 INN or Proposed INN: Not available yet Other descriptive ...	aTyr Pharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	32	Phase 1;Phase 2	United States;Netherlands;Italy
8	EUCTR2014-001753-17-NL (EUCTR)	19/09/2014	03/06/2014	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Activity of ATYR1940in ...	A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability ...	Facioscapulohumeral muscular dystrophy MedDRA version: 17.1;Level: PT;Classification code 10064087;T ...	Product Name: ATYR1940 Product Code: ATYR1940 INN or Proposed INN: N/A	aTyr Pharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	44	Phase 1;Phase 2	United States;France;Netherlands;Italy
9	NCT02239224 (ClinicalTrials.gov)	August 2014	7/9/2014	Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940in Adult Patients With Mu ...	A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability ...	Facioscapulohumeral Muscular Dystrophy (FSHD)	Biological: Placebo;Biological: ATYR1940	aTyr Pharma, Inc.	NULL	Completed	18 Years	65 Years	All	20	Phase 1/Phase 2	United States;France;Italy;Netherlands
10	EUCTR2014-001753-17-IT (EUCTR)	30/07/2014	13/06/2014	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Activity of ATYR1940in ...	A Placebo-Controlled, Randomized, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability ...	Facioscapulohumeral muscular dystrophy MedDRA version: 17.0;Level: PT;Classification code 10064087;T ...	Product Name: ATYR1940 Product Code: ATYR1940 INN or Proposed INN: N/A	aTyr Pharma, Inc.	NULL	Not Recruiting			Female: yes Male: yes	44	Phase 1;Phase 2	United States;France;Netherlands;Italy

First Previous1 2Next Last